Pediatric neurogenic bladder occurs when there’s a disconnect between your child’s bladder and nervous system, causing symptoms such as leaking pee or an overactive bladder. Share on Pinterest Getty ...
Royal College of Physicians (1991) 1991–2000 Aggressive treatment, prophylaxis and investigation of all children aged <7 years [81] American Academy of Pediatrics Guideline (1999) Aggressive treatment ...
Urinary tract infections (UTIs) rank among the most common bacterial illnesses in children, with peak incidence in infancy and early childhood. Clinical presentation often centres on fever without a ...
Urinary incontinence (UI) minimally affected academic performance except in children with psychiatric disorders. Children with UI and attention deficit-hyperactivity disorder had the worst academic ...
ZERBAXA The approvals were based on data from pediatric trials evaluating treatment for complicated intra-abdominal infections and complicated urinary tract infections. The Food and Drug ...
A new thulium fiber laser system may provide improved outcomes in the treatment of urinary stones for pediatric patients, compared to the current standard for laser lithotripsy, reports a study in The ...
In kids with a febrile urinary tract infection (UTI), an individualized duration of antibiotics led to an increased risk of recurrent UTI compared with a 10-day course. However, the individualized ...
Until recently, it was believed that human urine is sterile, but advanced culturing techniques and DNA sequencing have revealed that bacteria and other microbes—such as viruses and fungi—inhabit the ...
In very low birth weight (VLBW) infants, acute renal impairment (ARI) is common, but there is no consensus about criteria for its diagnosis. Neutrophil gelatinase-associated lipocalin (NGAL) is an ...
Spread the loveAs a parent, ensuring your child’s health and well-being is a top priority. One common health issue that can affect children is urinary tract infections (UTIs in kids). UTIs occur when ...
Dr. Stevenson completed a year as Pediatric Chief Resident at the University of Utah in 2004 and subsequently joined the University Of Utah Division Of Inpatient Medicine as a pediatric hospitalist.
The Food and Drug Administration has expanded the approval of Avycaz (ceftazidime and avibactam) to include pediatric patients aged ≥3 months for the treatment of complicated intra-abdominal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results